Class II<\/a> designation to a nationwide recall of over 3,700 bottles of blood pressure tablets manufactured by Macleods Pharma USA, Inc. The ongoing recall, which was initiated on October 7, is for two lots of Olmesartan Medoxomil, Amlodipine, and Hydrochlorothiazide Tablets.<\/p>\nRecalled blood pressure tablets<\/p>\n
Check any bottle you have for the following information, which identifies the products in each lot:<\/p>\n
The recall includes the following products:<\/p>\n
Olmesartan Medoxomil, Amlodipine, and Hydrochlorothiazide Tablets, 40 mg\/10 mg\/12.5 mg<\/p>\n
30-count bottleNDC: 33342-246-07Lot number: 12251163AExpiration date: May 31, 2027<\/p>\n
Olmesartan Medoxomil, Amlodipine, and Hydrochlorothiazide Tablets, 40 mg\/10 mg\/12.5 mg<\/p>\n
90-count bottleNDC: 33342-246-10Lot number: 12251163BExpiration date: May 31, 2027Reason for the recall<\/p>\n
FDA lists the reason as \u201cfailed dissolution specifications.\u201d This means the tablets did not meet specifications for how they dissolve during testing, so it may not be effective at lowering blood pressure. Class II status means that if you use or are exposed to a recalled product, you could suffer temporary or medically treatable health effects, or where the probability of serious health consequences is very unlikely.<\/p>\n
What to do if you have the recalled medicine <\/p>\n
Contact your health care provider right away, and follow their guidance as to whether you should continue taking the medication or get a replacement prescription. Do not stop taking any medication without first talking to your doctor.<\/p>\n","protected":false},"excerpt":{"rendered":"1 min readKey PointsOn October 26, the FDA issued a Class II recall for over 3,700 bottles of…\n","protected":false},"author":2,"featured_media":677195,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[34],"tags":[169372,1105,286844,1107,103,397,396,61,60,184510,1106,144979,286843,223989],"class_list":["post-677194","post","type-post","status-publish","format-standard","has-post-thumbnail","category-healthcare","tag-collection-recalls","tag-content-type-news","tag-contentid-b601b3ed-b0d1-4537-b542-5f40911b7979","tag-displaytype-standard-article","tag-health","tag-health-care","tag-healthcare","tag-ie","tag-ireland","tag-issyndicated-false","tag-locale-us","tag-read_time-2","tag-shorttitle-new-recall-check-your-blood-pressure-medication","tag-sponsored-false"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/posts\/677194","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/comments?post=677194"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/posts\/677194\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/media\/677195"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/media?parent=677194"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/categories?post=677194"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/tags?post=677194"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
![\"Estimated](\"https:\/\/www.goodhousekeeping.com\/_assets\/design-tokens\/fre\/static\/icons\/clock-regular.4ddebeb.svg\")
1 min read![\"Sparkle](\"https:\/\/www.goodhousekeeping.com\/_assets\/design-tokens\/fre\/static\/icons\/sparkle-regular.2aa06fe.svg\")
Key Points![\"Caret](\"https:\/\/www.goodhousekeeping.com\/_assets\/design-tokens\/fre\/static\/icons\/caret-right-regular.a6ec664.svg\"){kind=icon}
On October 26, the FDA issued a Class II recall for over 3,700 bottles of Olmesartan Medoxomil, Amlodipine, and Hydrochlorothiazide Tablets manufactured by Macleods Pharma USA due to failed dissolution specifications.The recalled tablets failed to meet dissolution standards during testing, meaning the blood pressure medication may not effectively lower blood pressure as intended for patients relying on it.Patients should immediately verify their bottle’s lot number and expiration date against the recall list, then contact their healthcare provider for guidance.<\/p>\n